{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:51:55Z","timestamp":1788367915264,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["NSFC82403761"],"award-info":[{"award-number":["NSFC82403761"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004829","name":"Science & Technology Department of Sichuan Province","doi-asserted-by":"crossref","award":["Science & Technology Department of Sichuan Province"],"award-info":[{"award-number":["Science & Technology Department of Sichuan Province"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]},{"name":"1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University","award":["23HXFH025"],"award-info":[{"award-number":["23HXFH025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-025-01132-y","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:19:50Z","timestamp":1767010790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Organoid-based drug screening identifies homoharringtonine as a therapeutic agent for anaplastic thyroid cancer via TFEB-mediated lysosomal dysfunction"],"prefix":"10.1007","volume":"49","author":[{"given":"Xinyue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"1132_CR1","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1530\/EJE-16-0574","volume":"175","author":"J Wendler","year":"2016","unstructured":"J. Wendler, M. Kroiss, K. Gast, M.C. Kreissl, S. Allelein, U. Lichtenauer, R. Blaser, C. Spitzweg, M. Fassnacht, M. Schott, D. F\u00fchrer, V. Tiedje, Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany. Eur. J. Endocrinol. 175, 521\u2013529 (2016)","journal-title":"Eur. J. Endocrinol."},{"key":"1132_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1089\/thy.2020.0944","volume":"31","author":"KC Bible","year":"2021","unstructured":"K.C. Bible, E. Kebebew, J. Brierley, J.P. Brito, M.E. Cabanillas, T.J. Jr. Clark, Di A. Cristofano, R. Foote, T. Giordano, J. Kasperbauer, K. Newbold, Y.E. Nikiforov et al., 2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 31, 337\u2013386 (2021)","journal-title":"Thyroid"},{"key":"1132_CR3","first-page":"425","volume":"331","author":"L Boucai","year":"2024","unstructured":"L. Boucai, M. Zafereo, M.E. Cabanillas, Thyroid Cancer: Rev. Jama. 331, 425\u2013435 (2024)","journal-title":"Thyroid Cancer: Rev. Jama"},{"key":"1132_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"S. Pushpakom, F. Iorio, P.A. Eyers, K.J. Escott, S. Hopper, A. Wells, A. Doig, T. Guilliams, J. Latimer, C. McNamee, A. Norris, P. Sanseau et al., Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41\u201358 (2019)","journal-title":"Nat. Rev. Drug Discov"},{"key":"1132_CR5","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Y. Xia, M. Sun, H. Huang, W.L. Jin, Drug repurposing for cancer therapy. Signal. Transduct. Target. Ther. 9, 92 (2024)","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1132_CR6","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"L. Broutier, G. Mastrogiovanni, M.M. Verstegen, H.E. Francies, L.M. Gavarr\u00f3, C.R. Bradshaw, G.E. Allen, R. Arnes-Benito, O. Sidorova, M.P. Gaspersz, N. Georgakopoulos, B.K. Koo et al., Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat. Med. 23, 1424\u20131435 (2017)","journal-title":"Nat. Med."},{"key":"1132_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","volume":"26","author":"Y Yao","year":"2020","unstructured":"Y. Yao, X. Xu, L. Yang, J. Zhu, J. Wan, L. Shen, F. Xia, G. Fu, Y. Deng, M. Pan, Q. Guo, X. Gao et al., Patient-Derived organoids predict chemoradiation responses of locally advanced rectal cancer. Cell. Stem Cell. 26, 17\u201326e6 (2020)","journal-title":"Cell. Stem Cell."},{"key":"1132_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/procel\/pwad038","volume":"15","author":"Y Mao","year":"2024","unstructured":"Y. Mao, W. Wang, J. Yang, X. Zhou, Y. Lu, J. Gao, X. Wang, L. Wen, W. Fu, F. Tang, Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids. Protein Cell. 15, 285\u2013304 (2024)","journal-title":"Protein Cell."},{"key":"1132_CR9","doi-asserted-by":"publisher","first-page":"bqae162","DOI":"10.1210\/endocr\/bqae162","volume":"166","author":"X Zhang","year":"2024","unstructured":"X. Zhang, J. Liu, Y. Ni, Y. Yang, T. Tian, X. Zheng, Z. Li, R. Huang, Modeling clinical radioiodine uptake by using organoids derived from differentiated thyroid cancer. Endocrinology. 166, bqae162 (2024)","journal-title":"Endocrinology"},{"issue":"8","key":"1132_CR10","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41418-022-01028-6","volume":"29","author":"A Tan","year":"2022","unstructured":"A. Tan, R. Prasad, C. Lee, E.H. Jho, Past, present, and future perspectives of transcription factor EB (TFEB): mechanisms of regulation and association with disease. Cell. Death Differ. 29(8), 1433\u20131449 (2022)","journal-title":"Cell. Death Differ."},{"key":"1132_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-111315-125407","volume":"32","author":"N Raben","year":"2016","unstructured":"N. Raben, R. Puertollano, TFEB, Linking lysosomes to cellular adaptation to stress. Annu. Rev. Cell. Dev. Biol. 32, 255\u2013278 (2016)","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"1132_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1470-2045(13)70152-9","volume":"14","author":"J Jin","year":"2013","unstructured":"J. Jin, J.X. Wang, F.F. Chen, D.P. Wu, J. Hu, J.F. Zhou, J.D. Hu, J.M. Wang, J.Y. Li, X.J. Huang, J. Ma, C.Y. Ji et al., Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial. Lancet Oncol. 14, 599\u2013608 (2013)","journal-title":"Lancet Oncol."},{"key":"1132_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.7150\/ijbs.44907","volume":"17","author":"LB Wang","year":"2021","unstructured":"L.B. Wang, D.N. Wang, L.G. Wu, J. Cao, J.H. Tian, R. Liu, R. Ma, J.J. Yu, J. Wang, Q. Huang, W.Y. Xiong, X. Zhang, Homoharringtonine inhibited breast cancer cells growth via miR-18a-3p\/AKT\/mTOR signaling pathway. Int. J. Biol. Sci. 17, 995\u20131009 (2021)","journal-title":"Int. J. Biol. Sci."},{"key":"1132_CR14","doi-asserted-by":"publisher","first-page":"8477","DOI":"10.1038\/srep08477","volume":"5","author":"W Cao","year":"2015","unstructured":"W. Cao, Y. Liu, R. Zhang, B. Zhang, T. Wang, X. Zhu, L. Mei, H. Chen, H. Zhang, P. Ming, L. Huang, Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6\/JAK1\/STAT3 signal pathway in Gefitinib-resistant lung cancer cells. Sci. Rep. 5, 8477 (2015)","journal-title":"Sci. Rep."},{"key":"1132_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41419-020-02902-2","volume":"11","author":"M Zhu","year":"2020","unstructured":"M. Zhu, Z. Gong, Q. Wu, Q. Su, T. Yang, R. Yu, R. Xu, Y. Zhang, Homoharringtonine suppresses tumor proliferation and migration by regulating EphB4-mediated \u03b2-catenin loss in hepatocellular carcinoma. Cell. Death Dis. 11, 632 (2020)","journal-title":"Cell. Death Dis."},{"key":"1132_CR16","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/jpp\/rgad055","volume":"75","author":"A Sarwar","year":"2023","unstructured":"A. Sarwar, Z. Zhu, M. Zhu, X. Tang, Q. Su, T. Yang, W. Tang, Y. Zhang, Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-JAK2-STAT3 axis. J. Pharm. Pharmacol. 75, 1294\u20131309 (2023)","journal-title":"J. Pharm. Pharmacol."},{"key":"1132_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1182\/blood.2023023400","volume":"144","author":"S Suo","year":"2024","unstructured":"S. Suo, D. Zhao, F. Li, Y. Zhang, S. Rodriguez-Rodriguez, L.X.T. Nguyen, L. Ghoda, N. Carlesso, G. Marcucci, B. Zhang, J. Jin, Homoharringtonine inhibits the NOTCH\/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia. Blood. 144, 1343\u20131347 (2024)","journal-title":"Blood"},{"key":"1132_CR18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/2159-8290.CD-19-0292","volume":"9","author":"RK Amaravadi","year":"2019","unstructured":"R.K. Amaravadi, A.C. Kimmelman, J. Debnath, Targeting autophagy in cancer: recent advances and future directions. Cancer Discov. 9, 1167\u20131181 (2019)","journal-title":"Cancer Discov"},{"key":"1132_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"A. Glaviano, A.S.C. Foo, H.Y. Lam, K.C.H. Yap, W. Jacot, R.H. Jones, H. Eng, M.G. Nair, P. Makvandi, B. Geoerger, M.H. Kulke, R.D. Baird et al., PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer. 22, 138 (2023)","journal-title":"Mol. Cancer"},{"key":"1132_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"M.S. Lawrence, P. Stojanov, C.H. Mermel, J.T. Robinson, L.A. Garraway, T.R. Golub, M. Meyerson, S.B. Gabriel, E.S. Lander, G. Getz, Discovery and saturation analysis of cancer genes across 21 tumour types. Nature. 505, 495\u2013501 (2014)","journal-title":"Nature"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01132-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01132-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:19:51Z","timestamp":1767010791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01132-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["1132"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01132-y","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Research Committee of the West China Hospital (2022\u2009\u2212\u20091642) in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}